NCT00285766已完成3 期
A Phase III, Open-Label Study of the Safety, Tolerability and Efficacy of the Selegiline Transdermal System in Elderly Subjects With Major Depression
Somerset Pharmaceuticals30 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2002年8月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 300
- 试验地点
- 30
研究概览
简要总结
Objective of this 16-week, open-label study is to assess the safety and tolerability of once daily application of three doses of STS during continuous dosing in the treatment of elderly subjects with major depression. Subjects will have study visits (clinic visits) at beginning of study (baseline) and study weeks 1, 3, 5, 8, 12, and 16.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 65 Years 至 —（Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Men/Women in good health 65 years or older
- •Ability to read, understand and sign study informed consent
- •Major depression- mild to severe based on rating scale
排除标准
- 未提供
研究者
研究点 (30)
Loading locations...
相似试验
已完成
3 期
A Study to Evaluate SAGE-217 in Adult Participants With Major Depressive Disorder (MDD)Major Depressive DisorderNCT03864614Biogen1,515
进行中（未招募）
3 期
A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILDPulmonary Hypertension Due to Lung DiseasesPulmonary Arterial HypertensionNCT04691154Liquidia Technologies, Inc.28
已完成
3 期
Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE)Hereditary Angioedema (HAE)NCT02865720Shire8
已完成
3 期
Pegzilarginase in Subjects <24 Months Old With Arginase 1 DeficiencyArginase 1 DeficiencyNCT06582524Immedica Pharma AB3
已完成
1 期
Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With LupusCutaneous LupusSystemic Lupus ErythematosusNCT03288324Children's Hospital Medical Center, Cincinnati13